Jeffrey J. Brown - 04 Nov 2022 Form 4 Insider Report for MEDIFAST INC (MED)

Role
Director
Signature
/s/ Jason L. Groves, attorney-in-fact
Issuer symbol
MED
Transactions as of
04 Nov 2022
Net transactions value
+$60,205
Form type
4
Filing time
10 Nov 2022, 17:33:59 UTC
Previous filing
27 Oct 2022
Next filing
05 Jan 2023
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction MED Common Stock Purchase $1,269 +12 +0.5% $106.93 2,366 08 Nov 2022 Direct F1
transaction MED Common Stock Purchase $58,936 +561 +1.6% $105.06 36,499 04 Nov 2022 By Brown Equity Partners, LLC F2, F3
holding MED Common Stock 3,940 04 Nov 2022 Jeffrey Brown Living Trust F4
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The shares were acquired pursuant to a dividend reinvestment feature in connection with deferred units held by the Reporting Person pursuant to the Medifast, Inc. Director's Deferred Compensation Plan (Amended and Restated). The shares accrued when and as dividends were paid on Medifast common stock.
F2 The shares were acquired by Brown Equity Partners, LLC, for which the reporting person is the managing member, pursuant to a broker-sponsored Dividend Reinvestment Plan.
F3 These shares are directly owned by Brown Equity Partners, LLC, for which the reporting persons is the managing member.
F4 These shares are directly owned by Jeffrey Brown Living Trust, for which the reporting person is the sole trustee and sole beneficiary.